[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_1632 

# __Use of coatings that have been proven safe for human health and the environment__

## Category to which it belongs

* [Implement rigorous cleaning and disinfection measures, including the use of antimicrobial materials and advanced technologies, to maintain a safe and hygienic environment.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_2.md)

## Closest similar item

* [Application of antimicrobial coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_574.md)
* [Rigorous testing and evaluation of different coating materials and formulations](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1631.md)
* [Antiviral surface coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_917.md)
* [Application of antiviral surface coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_921.md)
* [Regular monitoring of coated surfaces for changes in viral viability and development of alternative coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1633.md)
* [Disinfection of surfaces and development of antiviral coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1579.md)
* [Development of continuously active antimicrobial coatings and self-disinfecting surfaces.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2035.md)
* [Development of robust antiviral coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_920.md)
* [Regular cleaning and disinfection of high-touch surfaces, use of anti-SARS-CoV-2 coatings on solids](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1629.md)
* [Continuously active antimicrobial coating](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1190.md)

## Risks possibly mitigated by this Mitigation

* [Risk of adverse effects from anti-SARS-CoV-2 coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1180.md)

